Advanced Relapsed or Refractory Ovarian Cancer
1 clinical trials · Condition
◉ Watch Advanced Relapsed or Refractory Ovarian Cancer
| Record | Firm | Date |
|---|---|---|
| A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours) (NCT07306559) | Boehringer Ingelheim | 2026-02-27 |
Track Advanced Relapsed or Refractory Ovarian Cancer automatically
Every clearance here is in the API, with alerts when new ones post.